True. Almost a double in 2 months, but remember that's just from the 8-k being released. Trades going on now are from those who have been here and know the story, for the most part.
When CE mark is announced my gut feeling is that the PR (which will reach those who have never heard of CRMD will then want a piece of the pie even if just for a quick flip) will result in a spike near 2.5 to 3 range with the present uptick providing a nice spot to blast off from. Had CRMD been hanging in the .60's or .70's all this time my confidence would have waned a bit. Low float stocks like this are extremely volatile on big news. being listed on the NYSE will only help too. AND IF they announce "news with the news", it should get very interesting indeed.
We will all know soon!
Share price appreciation must be viewed in context of enterprise valuation. This is still very cheap. Approval likely puts fair value as a company at somewhere between $25MM and $40MM depending on whether you look at this as soley a dialysis product or as a generalized catheter product . If we don't pop much on approval, I will keep all of my shares.